Novo Integrated Sciences, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 22 rows, 22 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2024-01-16: Reporting owner David Christopher Mehlin; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2023-05-31: Reporting owner David Christopher Mehlin; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-08-09: Reporting owner Ali Sarfaraz; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-02-23: Reporting owner Oliva Robert Letterio; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-01-16 | David Christopher Mehlin Director, Officer (Chief Operating Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $0.78 exercise price | 2024-09-12 | |
| 2023-05-31 | David Christopher Mehlin Director, Officer (COO & President) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,000,000 2,000,000 owned after | $0.13 exercise price | 2023-06-02 | |
| 2022-08-09 | Ali Sarfaraz Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +39,480 39,480 owned after | $1.90 exercise price | 2022-08-10 | |
| 2022-02-23 | Oliva Robert Letterio Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +93,995 93,995 owned after | $1.33 exercise price | 2022-02-24 | |
| 2022-02-23 | Flesias Alex Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +93,995 93,995 owned after | $1.33 exercise price | 2022-02-24 | |
| 2022-02-23 | Pope Michael Ross Director | 4 | Stock option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +93,995 93,995 owned after | $1.33 exercise price | 2022-02-24 | |
| 2021-02-23 holding as of filing | Oliva Robert Letterio Director | 3/A | Stock Option (right to buy) Derivative · Direct | Holding | $1.60 exercise price | 2021-02-23 | ||
| 2021-02-23 holding as of filing | Oliva Robert Letterio Director | 3/A | Stock Option (right to buy) Derivative · Direct | Holding | $1.60 exercise price | 2021-02-23 | ||
| 2021-02-23 holding as of filing | Oliva Robert Letterio Director | 3/A | Stock Option (right to buy) Derivative · Direct | Holding | $3.80 exercise price | 2021-02-23 | ||
| 2021-02-19 holding as of filing | Pope Michael Ross Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.80 exercise price | 2021-02-19 | ||
| 2021-02-19 holding as of filing | Flesias Alex Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.80 exercise price | 2021-02-19 | ||
| 2021-02-19 holding as of filing | Oliva Robert Letterio Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $1.60 exercise price | 2021-02-19 | ||
| 2021-02-19 holding as of filing | Oliva Robert Letterio Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $1.60 exercise price | 2021-02-19 | ||
| 2021-02-19 holding as of filing | Oliva Robert Letterio Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.80 exercise price | 2021-02-19 | ||
| 2021-02-19 holding as of filing | David Christopher Mehlin Director, Officer (President) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $1.60 exercise price | 2021-02-19 | ||
| 2021-02-19 holding as of filing | David Christopher Mehlin Director, Officer (President) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $1.60 exercise price | 2021-02-19 | ||
| 2021-02-19 holding as of filing | David Christopher Mehlin Director, Officer (President) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $1.60 exercise price | 2021-02-19 | ||
| 2021-02-19 holding as of filing | David Christopher Mehlin Director, Officer (President) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $1.60 exercise price | 2021-02-19 | ||
| 2021-02-19 holding as of filing | David Christopher Mehlin Director, Officer (President) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $1.60 exercise price | 2021-02-19 | ||
| 2021-02-19 holding as of filing | David Christopher Mehlin Director, Officer (President) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $1.60 exercise price | 2021-02-19 | ||
| 2021-02-19 holding as of filing | David Christopher Mehlin Director, Officer (President) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.00 exercise price | 2021-02-19 | ||
| 2021-02-19 holding as of filing | Mattacchione Robert Director, Officer (Chief Executive Officer), 10% Owner | 3 | Stock Option (right to buy) Derivative · Indirect · By spouse | Holding | $1.60 exercise price | 2021-02-19 |